A phase III study of lisdexamfetamine for the treatment of attention deficit hyperactivity disorder in Japan

Trial Profile

A phase III study of lisdexamfetamine for the treatment of attention deficit hyperactivity disorder in Japan

Planning
Phase of Trial: Phase III

Latest Information Update: 13 Jan 2016

At a glance

  • Drugs Lisdexamfetamine (Primary)
  • Indications Attention-deficit hyperactivity disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jan 2016 New trial record
    • 15 Dec 2015 According to a Shire media release, company plans to initiate this study in 2016.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top